158 related articles for article (PubMed ID: 30247289)
1. An Uncommon Presentation of a Primary Bone Tumor: Anti-AMPA (Anti-α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid) Receptor Limbic/Paraneoplastic Encephalitis as a Presenting Feature of Ewing Sarcoma.
Koh D; Lau T; Teoh E; Lau KK
J Pediatr Hematol Oncol; 2018 Oct; 40(7):555-557. PubMed ID: 30247289
[TBL] [Abstract][Full Text] [Related]
2. [Anti-Ma2, anti-NMDA-receptor and anti-GluRε2 limbic encephalitis with testicular seminoma: short-term memory disturbance].
Kubota A; Tajima T; Narukawa S; Yamazato M; Fukaura H; Takahashi Y; Tanaka K; Shimizu J; Nomura K
Rinsho Shinkeigaku; 2012; 52(9):666-71. PubMed ID: 22989902
[TBL] [Abstract][Full Text] [Related]
3. Limbic encephalitis associated with antibodies against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor: a case report.
Zhu H; Hou YB; Gao JG; Zhao T; Zhou CK; Liu JY
Neuro Endocrinol Lett; 2018 May; 39(2):85-87. PubMed ID: 30183201
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review.
Wei YC; Huang CC; Liu CH; Kuo HC; Lin JJ
Brain Behav; 2017 Sep; 7(9):e00779. PubMed ID: 28948076
[TBL] [Abstract][Full Text] [Related]
5. Hashimoto's encephalitis associated with AMPAR2 antibodies: a case report.
Zhu M; Yu X; Liu C; Duan C; Li C; Zhu J; Zhang Y
BMC Neurol; 2017 Feb; 17(1):37. PubMed ID: 28222692
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric lupus erythematosus with neurogenic pulmonary edema and anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor limbic encephalitis: a case report.
Li R; Wang Y; Wu X; Wang J; Wei W; Li X
BMC Neurol; 2022 Jun; 22(1):222. PubMed ID: 35710378
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Anti-AMPA Receptor Limbic Encephalitis: A Case Report and Literature Review.
Fang Y; Pan D; Huang H
Front Neurol; 2021; 12():735983. PubMed ID: 34950098
[TBL] [Abstract][Full Text] [Related]
8. A Case of Paraneoplastic Limbic Encephalitis in a Patient with Invasive Thymoma with Anti-Glutamate Receptor Antibody-Positive Cerebrospinal Fluid: A Case Report.
Inoue T; Kanno R; Moriya A; Nakamura K; Watanabe Y; Matsumura Y; Suzuki H
Ann Thorac Cardiovasc Surg; 2018 Aug; 24(4):200-204. PubMed ID: 29269707
[TBL] [Abstract][Full Text] [Related]
9. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J
JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228
[TBL] [Abstract][Full Text] [Related]
10. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor.
Bataller L; Galiano R; García-Escrig M; Martínez B; Sevilla T; Blasco R; Vílchez JJ; Dalmau J
Neurology; 2010 Jan; 74(3):265-7. PubMed ID: 20083804
[No Abstract] [Full Text] [Related]
11. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis.
Wei YC; Liu CH; Lin JJ; Lin KJ; Huang KL; Lee TH; Chang YJ; Peng TI; Lin KL; Chang TY; Chang CH; Kuo HC; Chang KH; Cheng MY; Huang CC
J Neuroimmunol; 2013 Aug; 261(1-2):129-33. PubMed ID: 23796872
[TBL] [Abstract][Full Text] [Related]
12. Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody.
Ochiai S; Hayakawa I; Ohashi E; Hamano S; Miyata Y; Sakuma H; Hogetsu K; Gocho Y; Ogura M; Uchiyama T; Abe Y
Brain Dev; 2022 Oct; 44(9):630-634. PubMed ID: 35778314
[TBL] [Abstract][Full Text] [Related]
13. Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.
Zhang TY; Cai MT; Zheng Y; Lai QL; Shen CH; Qiao S; Zhang YX
Front Immunol; 2021; 12():652820. PubMed ID: 34093540
[TBL] [Abstract][Full Text] [Related]
14. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.
Lai M; Hughes EG; Peng X; Zhou L; Gleichman AJ; Shu H; Matà S; Kremens D; Vitaliani R; Geschwind MD; Bataller L; Kalb RG; Davis R; Graus F; Lynch DR; Balice-Gordon R; Dalmau J
Ann Neurol; 2009 Apr; 65(4):424-34. PubMed ID: 19338055
[TBL] [Abstract][Full Text] [Related]
15. Seronegative limbic encephalitis manifesting as subacute amnestic syndrome: a case report and review of the literature.
Ismail II; Alnaser F; Al-Hashel JY
J Med Case Rep; 2021 Mar; 15(1):130. PubMed ID: 33757596
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic limbic encephalitis with associated hypothalamitis mimicking a hyperdense hypothalamic tumor: a case report.
Bataduwaarachchi VR; Tissera N
BMC Med Imaging; 2016 Jan; 16():8. PubMed ID: 26782815
[TBL] [Abstract][Full Text] [Related]
17. Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.
Höftberger R; van Sonderen A; Leypoldt F; Houghton D; Geschwind M; Gelfand J; Paredes M; Sabater L; Saiz A; Titulaer MJ; Graus F; Dalmau J
Neurology; 2015 Jun; 84(24):2403-12. PubMed ID: 25979696
[TBL] [Abstract][Full Text] [Related]
18. [Partial non convulsive epileptic status as initial presentation of limbic encephalitis].
Abel CG; Kochen S; Cirio JJ; Sica RE
Rev Neurol; 2001 Apr 16-30; 32(8):734-7. PubMed ID: 11391508
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of limbic encephalitis in the cancer patient.
Kyritsis AP; Markoula S; Alexiou G; Asimakopoulos A; Jabbour P; Fotopoulos A; Sioka C
Future Oncol; 2020 Aug; 16(22):1647-1655. PubMed ID: 32511017
[TBL] [Abstract][Full Text] [Related]
20. The Peculiar Clinical Symptoms and Treatment of Limbic Encephalitis Associated with AMPA Receptor Antibody.
Jia Y; Li M; Wang H; Zhang M; Wang Y
Eur Neurol; 2021; 84(3):206-211. PubMed ID: 33857949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]